StockBased Compensation (Details 2) - Warrants Series A and Series B [Member]	9 Months Ended
	Sep. 30, 2024 $ / shares shares
Granted | shares	25,836,364
Number of warrants outstanding ending balance | shares	25,836,364
Weighted Average Exercise Price Outstanding balance	$ 0
Weighted Average Exercise Price, Granted	0.57
Weighted Average Exercise Price, Expired/Cancelled	0
Weighted Average Exercise Price, ending balance	0.57
Weighted Average Exercise Price, exercisable	$ 0